Lycopene suppresses lung cancer progression via PI3K/AKT pathway inhibition and apoptosis induction: mechanistic and safety insights from preclinical models.
- DOI
- 10.21037/tcr-2026-2067
- Published
- 2026 Oct 30
- Container
- Translational cancer research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21037/tcr-2026-2067,
title = {Lycopene suppresses lung cancer progression via PI3K/AKT pathway inhibition and apoptosis induction: mechanistic and safety insights from preclinical models.},
author = {Gu H and Pan C and Xu Q and Lu J and Zhao T and Fu K and Yan X and Xu Y and Ye J},
year = {2026},
journal = {Translational cancer research},
doi = {10.21037/tcr-2026-2067},
url = {https://doi.org/10.21037/tcr-2026-2067}
}RIS
TY - JOUR TI - Lycopene suppresses lung cancer progression via PI3K/AKT pathway inhibition and apoptosis induction: mechanistic and safety insights from preclinical models. AU - Gu H AU - Pan C AU - Xu Q AU - Lu J AU - Zhao T AU - Fu K AU - Yan X AU - Xu Y AU - Ye J PY - 2026 JO - Translational cancer research DO - 10.21037/tcr-2026-2067 UR - https://doi.org/10.21037/tcr-2026-2067 ER -
APA
H, G., C, P., Q, X., J, L., T, Z., K, F., X, Y., Y, X., & J, Y. (2026). Lycopene suppresses lung cancer progression via PI3K/AKT pathway inhibition and apoptosis induction: mechanistic and safety insights from preclinical models.. Translational cancer research. https://doi.org/10.21037/tcr-2026-2067
Source records
- pubmed · retrieved 2026-11-10T12:32:24.886Z